55% Mesenchymal Stem Cell (MSC) Therapy · 25% Exosome Therapy · 20% Platelet-Rich Plasma (PRP)
Starting from
$6,500

Investigational autologous bone marrow cell therapy for long COVID and post-viral illness, alongside interventional orthopedics
Boulder Biologics opened in 2018 on the Boulder Community Health Foothills campus and spends most of its week on non-operative interventional orthopedics: bone marrow aspirate concentrate, microfragmented fat, PRP and its variants, prolotherapy, hydrodissection. The long COVID program grew out of that same autologous approach. The protocol is bone marrow drawn from the patient's own posterior superior iliac spine under local anesthetic, filtered on site with minimal processing, and given back during the same visit. It goes in by IV, and for selected cases by intranasal atomization. Follow-up is at six and twelve weeks. To be a candidate you need symptoms that have lasted at least three months, a documented infection, and other explanations ruled out. What separates this clinic from most of the market is how it talks about evidence. Its long COVID page opens by stating that no stem cell or cellular therapy has been approved by the FDA for long COVID or post-COVID conditions. It says outright that it does not use donor-derived or culture-expanded cells sold as stem cell injections, only your own, minimally manipulated. On PRP it says effectiveness is variable and the evidence is strongest for knee osteoarthritis, tennis elbow, and rotator cuff tendinopathy. It also turns people away: advanced, diffuse arthritis typically does not respond, and those patients get referred elsewhere. The first visit is a 45 to 60 minute consultation with the physician, and the clinic's own line is that you leave with a plan rather than a sales pitch. Jason Glowney founded the practice. He trained in internal medicine, holds a sports medicine certificate of added qualification from a University of Colorado fellowship, and practiced at the Boulder Center for Sports Medicine and CU Sports Medicine before going out on his own. In 2025 he started the Apeiron Research Center, a nonprofit running IRB-approved investigator-led trials in cellular therapy.
Board-Certified Physicians
Research / Clinical-Trial Participation
Accreditations are records-based and do not imply endorsement of any treatment's safety or efficacy.
Starting from
On consultation
consult to quote
Pricing depends on the joint, the number of sites, and the formulation, and is given at the consultation. Most plans classify autologous biologic procedures as investigational and do not cover them, so everything is self-pay. HSA and FSA funds usually work and the clinic provides itemized documentation for them. Payment plans at 0% APR are available.
Pricing is indicative and set by each clinic. Confirm the final cost directly before treatment.
Individual results vary and are not typical or guaranteed. Case studies and testimonials reflect one person's experience.
Dr. Jason Glowney
Founder and Physician
MD, MSc, board certified in internal medicine with a CAQ in sports medicine
Glowney earned his MD at the University of Chicago and completed a sports medicine fellowship at the University of Colorado in 2009. He trained across internal medicine, emergency medicine, and interventional orthopedics, and has practiced biologic orthopedics in Boulder for more than a decade, previously at the Boulder Center for Sports Medicine and CU Sports Medicine. He later added a master's in applied mathematics from the University of Washington and now works on machine learning applied to orthobiologics outcomes. He founded the Apeiron Research Center in 2025 and is its principal investigator.
Ryan Shiling
Co-Founder and Clinical Staff
RN
Shiling co-founded Boulder Biologics and handles clinical care through the procedure and follow-up. He completes nurse practitioner training in 2026.
Not yet verified
This clinic has not completed verification. Listings are still curated, but accreditation hasn't been confirmed.
Share a few details and Boulder Biologics will reach out by email. Your information is never shown publicly.
55% Mesenchymal Stem Cell (MSC) Therapy · 25% Exosome Therapy · 20% Platelet-Rich Plasma (PRP)
Starting from
$6,500
40% Regenerative Orthopedics · 30% Bone-Marrow-Derived Therapy · 20% Platelet-Rich Plasma (PRP)
Pricing on consultation
45% Adipose-Derived Stem Cell Therapy · 30% Stromal Vascular Fraction (SVF) · 25% Exosome Therapy
Starting from
$4,000